RESUMEN

Cattle are less active than humans. Hence, it was hypothesized in this study that transmitting acceleration signals at a 1 min sampling interval to reduce storage load has the potential to improve the performance of motion sensors without affecting the precision of behavior classification. The behavior classification performance in terms of precision, sensitivity, and the F1-score of the 1 min serial datasets segmented in 3, 4, and 5 min window sizes based on nine algorithms were determined. The collar-fitted triaxial accelerometer sensor was attached on the right side of the neck of the two fattening Korean steers (age: 20 months) and the steers were observed for 6 h on day one, 10 h on day two, and 7 h on day three. The acceleration signals and visual observations were time synchronized and analyzed based on the objectives. The resting behavior was most correctly classified using the combination of a 4 min window size and the long short-term memory (LSTM) algorithm which resulted in 89% high precision, 81% high sensitivity, and 85% high F1-score. High classification performance (79% precision, 88% sensitivity, and 83% F1-score) was also obtained in classifying the eating behavior using the same classification method (4 min window size and an LSTM algorithm). The most poorly classified behavior was the active behavior. This study showed that the collar-fitted triaxial sensor measuring 1 min serial signals could be used as a tool for detecting the resting and eating behaviors of cattle in high precision by segmenting the acceleration signals in a 4 min window size and by using the LSTM classification algorithm.

Asunto(s)

Aceleración , Conducta Alimentaria , Acelerometría/métodos , Algoritmos , Animales , Bovinos , Recolección de Datos , Humanos , Lactante

RESUMEN

We hypothesized that the unsaturated fatty acid palmitoleic acid (POA) could promote the expression of adipogenic/lipogenic genes in bovine skeletal muscle satellite cells (BSCs). The BSCs were cultured in a growth medium containing 10% fetal bovine serum. When the cells reached 80%-90% confluence, we used the differentiation medium with 5% horse serum for differentiation for 96 h. The differentiation medium contained 50 µM, 100 µM and 200 µM POA. Control BSC were cultured only in differentiation media. Compared with the control BSC, the POA BSC significantly up-regulated the expression of paired box 3 (Pax3) and paired box 7 (Pax7) and down-regulated myogenin gene expression (p < 0.01), which indicates a depression in muscle fiber development. However, all POA treatments up-regulated the expression of the adipocyte transcription factors peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer-binding protein alpha and beta (C/EBP α and C/EBP ß), and other genes (p < 0.01) and increased the expression of PAT-family proteins and the concentration of adiponectin in the media. These results indicate that POA can convert part of BSCs into adipocytes.

RESUMEN

Ciglitazone is a member of the thiazolidinedione family, and specifically binds to peroxisome proliferator-activated receptor-γ (PPARγ), thereby promoting adipocyte differentiation. We hypothesized that ciglitazone as a PPARγ ligand in the absence of an adipocyte differentiation cocktail would increase adiponectin and adipogenic gene expression in bovine satellite cells (BSC). Muscle-derived BSCs were isolated from six, 18-month-old Yanbian Yellow Cattle. The BSC were cultured for 96 h in differentiation medium containing 5 µM ciglitazone (CL), 10 µM ciglitazone (CM), or 20 µM ciglitazone (CH). Control (CON) BSC were cultured only in a differentiation medium (containing 2% horse serum). The presence of myogenin, desmin, and paired box 7 (Pax7) proteins was confirmed in the BSC by immunofluorescence staining. The CL, CM, and CH treatments produced higher concentrations of triacylglycerol and lipid droplet accumulation in myotubes than those of the CON treatment. Ciglitazone treatments significantly increased the relative expression of PPARγ, CCAAT/enhancer-binding protein alpha (C/EBPα), C/EBPß, fatty acid synthase, stearoyl-CoA desaturase, and perilipin 2. Ciglitazone treatments increased gene expression of Pax3 and Pax7 and decreased expression of myogenic differentiation-1, myogenin, myogenic regulatory factor-5, and myogenin-4 (p < 0.01). Adiponectin concentration caused by ciglitazone treatments was significantly greater than CON (p < 0.01). RNA sequencing showed that 281 differentially expressed genes (DEGs) were found in the treatments of ciglitazone. DEGs gene ontology (GO) analysis showed that the top 10 GO enrichment significantly changed the biological processes such as protein trimerization, negative regulation of cell proliferation, adipocytes differentiation, and cellular response to external stimulus. Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that DEGs were involved in the p53 signaling pathway, PPAR signaling pathway, biosynthesis of amino acids, tumor necrosis factor signaling pathway, non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, and Wnt signaling pathway. These results indicate that ciglitazone acts as PPARγ agonist, effectively increases the adiponectin concentration and adipogenic gene expression, and stimulates the conversion of BSC to adipocyte-like cells in the absence of adipocyte differentiation cocktail.